Cold Hard Facts of Cryoglobulinemia Updates on Clinical Features and Treatment Advances

被引:20
作者
Ghetie, Daniela [1 ]
Mehraban, Navid [1 ]
Sibley, Cailin H. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Vasculitis Ctr, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA
关键词
Cryoglobulinemia; Cryoglobulinemic; Vasculitis; Rituximab; HCV; Diagnosis; Treatment; HEPATITIS-C VIRUS; ESSENTIAL MIXED CRYOGLOBULINEMIA; RANDOMIZED CONTROLLED-TRIAL; TERM FOLLOW-UP; PERIPHERAL NEUROPATHY; CLASSIFICATION CRITERIA; HYPERVISCOSITY SYNDROME; MORPHOLOGIC SPECTRUM; RITUXIMAB TREATMENT; I CRYOGLOBULINEMIA;
D O I
10.1016/j.rdc.2014.09.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cryoglobulins are immunoglobulins that precipitate at temperatures less than 37 degrees C. They occur secondary to infectious, autoimmune, and malignant processes. In the Brouet classification, type I cryoglobulinemia is caused by hyperviscosity, whereas type II and III manifestations are caused by vasculitis in target organs (primarily skin, peripheral nerves, and kidney). New classification criteria were recently proposed that may help with study and treatment of cryoglobulinemic vasculitis (CryoVas). Hepatitis C virus is the most common cause of CryoVas and treatment with antivirals can be curative in mild cases, whereas rituximab is highly effective in treating active vasculitis in more severe cases.
引用
收藏
页码:93 / +
页数:18
相关论文
共 102 条
[1]   A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].
AGNELLO, V ;
CHUNG, RT ;
KAPLAN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495
[2]  
Amital H, 2005, CLIN EXP RHEUMATOL, V23, P616
[3]   Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa [J].
Batisse, D ;
Karmochkine, M ;
Jacquot, C ;
Kazatchkine, MD ;
Weiss, L .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (07) :701-703
[4]   The clinical and morphologic spectrum of renal cryoglobulinemia [J].
Beddhu, S ;
Bastacky, S ;
Johnson, JP .
MEDICINE, 2002, 81 (05) :398-409
[5]   THE CLINICOPATHOLOGIC FEATURES OF CRYOGLOBULINEMIC NEPHROPATHY [J].
BENBASSAT, M ;
BONER, G ;
ROSENFELD, J ;
PICK, AI ;
KAHANA, M ;
HAZAZ, B ;
HOCHMAN, B .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1983, 79 (02) :147-156
[6]   Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review [J].
Besada, Emilio ;
Vik, Anders ;
Koldingsnes, Wenche ;
Nossent, Johannes C. .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (06) :800-803
[7]   Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia [J].
Boglione, Lucio ;
D'Avolio, Antonio ;
Cariti, Giuseppe ;
Di Perri, Giovanni .
JOURNAL OF CLINICAL VIROLOGY, 2013, 56 (02) :167-169
[8]   LUNG INVOLVEMENT IN ESSENTIAL MIXED CRYOGLOBULINEMIA [J].
BOMBARDIERI, S ;
PAOLETTI, P ;
FERRI, C ;
DIMUNNO, O ;
FORNAI, E ;
GIUNTINI, C .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (05) :748-756
[9]  
Bonnet F, 2003, J RHEUMATOL, V30, P2005
[10]   CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis [J].
Boyer, O ;
Saadoun, D ;
Abriol, J ;
Dodille, M ;
Piette, JC ;
Cacoub, P ;
Klatzmann, D .
BLOOD, 2004, 103 (09) :3428-3430